Agios Pharmaceuticals | 4:持股变动声明-董事 Scadden David
Agios Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(3.88%),Steven Boyd(3.88%)
Agios Pharmaceuticals | 4:持股变动声明-高管 Washburn Theodore James Jr.
Agios Pharmaceuticals | 4:持股变动声明-董事 Ballal Rahul D.
Agios Pharmaceuticals | 4:持股变动声明-高管 Burns James William
Agios Pharmaceuticals | 144:拟议出售证券
Agios Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Joshua J. Dapice(9.9%),Philip D. Dreyfuss(9.9%)等
Agios Pharmaceuticals | 144:拟议出售证券
Agios Pharmaceuticals | 144:拟议出售证券
Agios Pharmaceuticals | 10-Q:2024财年三季报
Agios Pharmaceuticals | 8-K:Agios报告业务亮点和2024年第三季度财务业绩
Agios Pharmaceuticals | 4:持股变动声明-高管 Jones Cecilia
Agios Pharmaceuticals | 4:持股变动声明-董事 Ballal Rahul D.
Agios Pharmaceuticals | 4:持股变动声明-董事 Smith Cynthia
Agios Pharmaceuticals | 4:持股变动声明-高管 Goff Brian
Agios Pharmaceuticals | 144:拟议出售证券
Agios Pharmaceuticals | 10-Q:2024财年二季报
Agios Pharmaceuticals | 8-K:Agios报告业务亮点和2024年第二季度财务业绩
Agios Pharmaceuticals | 4:持股变动声明-高管 Gheuens Sarah
Agios Pharmaceuticals | 144:拟议出售证券